ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Adolescent Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,475Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 18

$422K Total Retail Price of All Prescriptions

Rank: 5 out of 18

329 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 329 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

18% of this provider’s 329 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 7,324 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
SIMVASTATIN 511 420 1 1
AMLODIPINE BESYLATE 397 322 2 3
LISINOPRIL 366 316 3 2
ATENOLOL 338 301 4 11
HYDROCODONE-ACETAMINOPHEN 321 128 S3 5 14
OMEPRAZOLE 303 216 6 4
FUROSEMIDE 246 214 7 7
WARFARIN SODIUM 243 195 8 12
TRIAMTERENE-HCTZ 229 212 9 19
LEVOTHYROXINE SODIUM 213 166 10 5
GABAPENTIN 206 125 11 13
ALENDRONATE SODIUM 192 170 12 21
POTASSIUM CHLORIDE 173 153 13 20
METFORMIN HCL 171 134 14 6
HYDRALAZINE HCL 163 157 15 53
RANITIDINE HCL 140 102 16 36
PRAVASTATIN SODIUM 123 84 17 18
NEXIUM 122 76 18 22
SYMBICORT 120 52 19 63
PREDNISONE 114 90 20 40
PROAIR HFA 114 53 20 31
CARVEDILOL 110 86 22 29
ATORVASTATIN CALCIUM 108 96 23 9
GLIMEPIRIDE 104 79 24 49
TAMSULOSIN HCL 103 102 25 39
CITALOPRAM HBR 95 80 26 17
FLUTICASONE PROPIONATE 87 67 27 28
DONEPEZIL HCL 82 82 28 32
CLONIDINE HCL 80 60 29 57
OXYCODONE-ACETAMINOPHEN 79 15 S2 30 25
AZITHROMYCIN 78 65 31 47
METOPROLOL SUCCINATE 77 77 32 15
METOPROLOL TARTRATE 75 71 33 10
FAMOTIDINE 73 55 34 61
LANTUS 60 47 35 66
ALLOPURINOL 60 52 35 48
KLOR-CON M20 59 59 37 44
LOSARTAN POTASSIUM 58 57 38 16
LISINOPRIL-HYDROCHLOROTHIAZIDE 57 17 39 30
FINASTERIDE 57 50 39 65
CARBIDOPA-LEVODOPA 56 56 41 59
TRAMADOL HCL 55 48 42 23
SPIRIVA 54 19 43 45
ADVAIR DISKUS 53 42 44 41
ACTOS 53 37 44 50
LIDOCAINE 52 52 46 92
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 27, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.